Meir Jakobsohn
Founder and CEO

Meir Richter
VP Operations

Ariel Gross
VP and CFO

Mira Rotner
VP Pharma

Yael Zidky
VP, Human Resources & Compliance

Prof. Amos Pines, MD.
VP Medical

Yoel Lipschitz
VP Regulatory Affairs

Gil Gurfinkel
VP, Corporate Development

Meir Jakobsohn founded Medison Ltd. in 1996 and spearheaded its growth as a leading international marketing group. He is the third generation of his family to help shape the local healthcare industry. Previously Meir served as the Chief Operating Officer of M. Jakobsohn Ltd., led by Arye Jakobsohn. M. Jakobsohn Ltd. was a pioneer in opening the local market to global pharmaceutical concerns like Ciba-Geigy (Novartis), which it represented between 1937 and 1995. Meir holds a BA in Economics from Bar-Ilan University and an Executive MBA from Bradford University in the UK.

Meir brings over twenty years of experience in management, marketing and sales in the medical and diagnostic markets. Prior to joining the Medison Group, he served as Manager of OTC products at Ciba-Geigy (Novartis) representative Jakobsohn Ltd. Meir also served as Marketing Manager at Promedico Ltd., and as Managing Director of Pharmatope Ltd. Meir holds a B.A. in Social Sciences and Economics from Bar Ilan University and an MBA from Manchester University.

An experienced financial executive, Ariel served as Chief Financial Officer for the NSI Group and Sarel Products and Solutions for Advanced Medicine prior to joining the Medison Group. He is a qualified accountant in Israel since 1996, and holds a BCompt degree from UNISA (University of South-Africa) and an MBA from Harriott-Watt University (Scotland).

Mira manages the Pharma Division, specializing in Oncology, Hematology, Endocrinology and Human Genetic Therapies. Prior to joining the Medison Group in 2006, Mira served as a Sales Manager, Product Manager and Business Unit Manager for C.T.S. Ltd., and was a registered dietician at the Sheba Medical Center. Mira holds a B.Sc. in Biochemistry and Food Science from the Hebrew University of Jerusalem and an MBA from the Ono Academic College.

Yael is responsible for establishing global policies, procedures, compensation structures, organizational development, recruitment and benefits. In her role as Vice President for Compliance, Yael oversees Medison's compliance program to ensure correlation with partners in all related ethical business. Yael joined the Medison Group after serving as Vice President of Human Resources at IXI Mobile Inc. There she provided executive coaching and guidance, as well as support with management development, organizational development, change management, talent review, and succession planning. Prior to IXI Mobile, Yael served as a senior Human Resources Manager at Terayon Communication Systems Ltd. Yael holds a B.A. (Honors) in Economics and an MBA (Honors) from the Israel College of Management.

Prof. Pines is a Clinical Associate Professor at Tel Aviv University’s Sackler School of Medicine. He brings extensive experience in conducting clinical trials for multinational companies, and has published over 100 studies in prestigious medical journals. Prof. Pines holds a B.Sc. in Biology from the Hebrew University of Jerusalem, and an M.D. from Hadassah Medical School, Jerusalem.

Adv. Yoel Lipschitz served as a Senior Executive with 18 years' experience in Governmental, legal and regulatory management. Prior to joining Medison , Yoel was  Deputy Director General for Health Care Organizations & Supplementary Insurance  in the Ministry of Health and a member of the National Health Services  Committee .Yoel  specializes  in policy setting, pharmaceuticals and medical devices Regulations, pricing  and technology assessment. Yoel holds a LLB in Law, BA in Economics and an Executive MBA from Bar-Ilan University. 
Yoel also serves as General Manager at Lavi Medtech Ltd.

Gil joined Medison in 2015 and is responsible for the strategic development of Medison Group. Gil brings vast experience in business strategy, management consulting, corporate finance, private equity and capital markets.

Prior to joining Medison, Gil has been a Vice President at the private equity fund Shamrock Israel, where he led multiple investments and acted as a Chairman and board member of multiple Israeli and International companies.

Gil holds a BSc (cum laude) from the Technion, the Israel Institute of Technology, and an MBA from the Recanati Business School at Tel Aviv University.